BIT biotron limited

0.00%

0.2¢

" Significant value created, derisking the platform, ...." were...

First 47 Last

Share
Profile

Follow
a2zz

942 Posts.

145

07/02/25

09:50

Post #: 77748435
Share
Originally posted by numbnuts01: ↑

Biotron's Funding Requirements
Biotron needs to raise capital to fund future trials.
These trials are essential to demonstrate results that could attract potential partners or investors.

Trial Cost Estimation
Michelle Miller estimates that a trial would cost between $1.5M to $2.5M.
To stay on the safe side, let's assume they aim to raise $2M to cover costs.

Capital Raise via Share Issuance
If they were to raise $2M at a share price of 1 cent (0.01 AUD):
Number of new shares issued = $2,000,000 ÷ 0.01 = 200 million shares
This would significantly dilute the existing shareholders.

Dilution Concerns
If Biotron proceeds with this capital raise:
The total shares on issue will increase by 200 million.
Existing shareholders will see their ownership percentage reduced.
The company may face negative market perception due to dilution.

Alternative Approaches
Higher Share Price Offering:
If Biotron can demonstrate value or secure early interest, they may be able to issue shares at a higher price (e.g., 2c instead of 1c), reducing dilution.
Partner Funding:
Instead of issuing more shares, Biotron could seek strategic partnerships where a partner co-funds the trial.
Grant or Government Funding:
Biotech grants or R&D incentives may be available to offset costs.
Convertible Notes:
A convertible note structure could attract investors without immediate dilution.

Management has no idea of what to do, so most likely, none of the above will have crossed their minds, and at best, a cheap takeover could occur, and SHs get a big thank you for supporting the Lifestyle of MnM and PN

Expand

" Significant value created, derisking the platform, ...." were MM's words to entice SHs.
They clueless, but they're super voracious to grub SHs and tax payers' remaining funds.
SHs demand
more clarity from the management no matter what, and a pause of their salaries and entitlements until further tangible outcome.
BIT Price at posting: 1.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 47 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$210	104.8K

Buyers (Bids)

No.	Vol.	Price($)
64	38848316	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	18281126	25

View Market Depth

No.	Vol.	Price($)
59	37148316	0.002
33	65631001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14162401	23
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 12.28pm 27/06/2025 (20 minute delay)

BIT (ASX) Chart

" Significant value created, derisking the platform, ...." were...

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

" Significant value created, derisking the platform, ...." were...

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News